Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers

D. M. Brett-Major, P. T. Scott, T. A. Crowell, C. S. Polyak, K. Modjarrad, M. L. Robb, D. L. Blazes

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The HIV pandemic persists globally and travelers are at risk for infection by the Human Immunodeficiency Virus (HIV). While HIV-focused guidelines delineate risk stratification and mitigation strategies for people in their home communities, travel issues are not addressed. In this review, direct and indirect evidence on HIV risk among travelers is explored. The burgeoning practice of employing pre-exposure prophylaxis (PrEP) with anti-retroviral therapy in the non-travel setting is introduced, as well as the more established use of post-exposure prophylaxis (PEP). Challenges in applying these lessons to travelers are discussed, and a new guidelines process is scoped and recommended.

Original languageEnglish (US)
Article number25
JournalTropical Diseases, Travel Medicine and Vaccines
Issue number1
StatePublished - Nov 28 2016
Externally publishedYes


  • Human Immunodeficiency Virus
  • Post-exposure
  • Pre-exposure
  • Prophylaxis
  • Review
  • Travel

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers'. Together they form a unique fingerprint.

Cite this